FI923289A7 - Osteoporoosin käsittelyyn käytettävät trifluorimetyylibentsyylifosfonaatit - Google Patents

Osteoporoosin käsittelyyn käytettävät trifluorimetyylibentsyylifosfonaatit Download PDF

Info

Publication number
FI923289A7
FI923289A7 FI923289A FI923289A FI923289A7 FI 923289 A7 FI923289 A7 FI 923289A7 FI 923289 A FI923289 A FI 923289A FI 923289 A FI923289 A FI 923289A FI 923289 A7 FI923289 A7 FI 923289A7
Authority
FI
Finland
Prior art keywords
trifluoromethylbenzylphosphonates
treat osteoporosis
osteoporosis
treat
trifluoromethylbenzylphosphonates used
Prior art date
Application number
FI923289A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI923289A0 (fi
FI923289L (fi
Inventor
Charles F Schwender
Keith Demarest
David Juergen Wustrow
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of FI923289A0 publication Critical patent/FI923289A0/fi
Publication of FI923289A7 publication Critical patent/FI923289A7/fi
Publication of FI923289L publication Critical patent/FI923289L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3882—Arylalkanephosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI923289A 1991-07-18 1992-07-17 Trifluormetylbensylfosfonat anvaendbara vid behandling av osteoporos FI923289L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/732,267 US5300687A (en) 1991-07-18 1991-07-18 Trifluoromethylbenzylphosphonates useful in treating osteoporosis

Publications (3)

Publication Number Publication Date
FI923289A0 FI923289A0 (fi) 1992-07-17
FI923289A7 true FI923289A7 (fi) 1993-01-19
FI923289L FI923289L (fi) 1993-01-19

Family

ID=24942866

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923289A FI923289L (fi) 1991-07-18 1992-07-17 Trifluormetylbensylfosfonat anvaendbara vid behandling av osteoporos

Country Status (14)

Country Link
US (2) US5300687A (enExample)
EP (1) EP0524023A1 (enExample)
JP (1) JPH05213977A (enExample)
KR (1) KR930002364A (enExample)
CN (1) CN1070408A (enExample)
AU (1) AU657146B2 (enExample)
CA (1) CA2074020A1 (enExample)
FI (1) FI923289L (enExample)
HU (1) HUT62907A (enExample)
IE (1) IE922341A1 (enExample)
MX (1) MX9204229A (enExample)
NO (1) NO922851L (enExample)
TW (1) TW216796B (enExample)
ZA (1) ZA925391B (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300687A (en) * 1991-07-18 1994-04-05 Ortho Pharmaceutical Corporation Trifluoromethylbenzylphosphonates useful in treating osteoporosis
ZA941088B (en) * 1993-02-19 1995-09-27 Symphar Sa Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them
EP0625522B1 (en) * 1993-05-18 1998-08-19 Takeda Chemical Industries, Ltd. Benzopyran derivatives and their use
DE69520360T2 (de) * 1994-07-04 2001-08-09 Takeda Chemical Industries, Ltd. Phosphonsäure verbindungen imre herstellung und verwendung
US5691153A (en) * 1996-09-06 1997-11-25 Creighton University Genetic markers to detect high bone mass
US5922697A (en) * 1996-10-02 1999-07-13 Warner-Lambert Company Compounds, compositions and methods for inhibiting the binding of proteins containing an SH2 domain to cognate phosphorylated proteins
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) * 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6911553B1 (en) 1997-10-02 2005-06-28 Roche Diagnostics Gmbh Osteoblast-specific mitogens and drugs containing such compounds
EP0906759A1 (de) * 1997-10-02 1999-04-07 Roche Diagnostics GmbH Neue Osteoblastenspezifische Mitogene: Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
FR2771102B1 (fr) * 1997-11-14 2000-12-15 Biocoral Inc Procede pour induire la differenciation osteoblastique de cellules de tissu adipeux extramedullaire humain
US6979728B2 (en) * 1998-05-04 2005-12-27 Baylor College Of Medicine Articles of manufacture and methods for array based analysis of biological molecules
WO2000028982A2 (en) 1998-11-19 2000-05-25 The Board Of Trustees For The University Of Arkansas Increasing bone strength with selected bisphosphonates
US20020150887A1 (en) * 2000-11-09 2002-10-17 National Institute Of Advanced Industrial Science And Technology Methods and nucleic acid probes for molecular genetic analysis of polluted environments and environmental samples
US20050032060A1 (en) * 2001-08-31 2005-02-10 Shishir Shah Arrays comprising pre-labeled biological molecules and methods for making and using these arrays
AU2002367886B8 (en) 2001-10-12 2008-08-14 Perkinelmer Las, Inc. Compilations of nucleic acids and arrays and methods of using them
US7439346B2 (en) * 2001-10-12 2008-10-21 Perkinelmer Las Inc. Nucleic acids arrays and methods of use therefor
US6916621B2 (en) * 2002-03-27 2005-07-12 Spectral Genomics, Inc. Methods for array-based comparitive binding assays
DE10259245A1 (de) 2002-12-17 2004-07-01 Merck Patent Gmbh Derivate des Asimadolins mit kovalent gebundenen Säuren
EP1622623A4 (en) * 2003-04-11 2009-03-18 Barr Lab Inc METHOD FOR THE ADMINISTRATION OF ESTROGENIC AND TESTED
WO2005090370A1 (en) 2004-02-05 2005-09-29 The Regents Of The University Of California Pharmacologically active agents containing esterified phosphonates and methods for use thereof
WO2006025995A2 (en) * 2004-07-27 2006-03-09 The Regents Of The University Of California Compositions and methods using md-2 mutants and chimeric proteins
CN1302001C (zh) * 2005-01-20 2007-02-28 申厚宝 邻氯苄基膦酸二甲酯生产工艺
EP1865967A4 (en) * 2005-04-08 2011-02-09 Chimerix Inc COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND OTHER DISEASES
JP2008535862A (ja) 2005-04-08 2008-09-04 キメリクス，インコーポレイテッド ポックスウイルス感染の治療のための化合物、組成物および方法
US20100221345A1 (en) 2006-01-18 2010-09-02 National University Corporation Tokyo Medical And Osteogenic biomaterial containing osteogenesis promoting substance and nanogel
AU2008232954A1 (en) 2007-03-30 2008-10-09 Tioga Pharmaceuticals Inc. Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome
AU2009206673B2 (en) * 2008-01-25 2015-04-23 Chimerix, Inc. Methods of treating viral infections
JP5670329B2 (ja) 2008-07-18 2015-02-18 ジョージア・テック・リサーチ・コーポレーション 有機電子デバイス用の、修飾された仕事関数を有する安定した電極および方法
WO2010019696A2 (en) * 2008-08-12 2010-02-18 Allylix, Inc. Method for production of isoprenoids
CA2734922C (en) 2008-09-15 2020-01-14 Genentech, Inc. Compositions comprising polynucleotides comprising hybrid osmo-responsive transcriptional regulatory elements and methods for producing a protein under conditions of hyperosmolarity
JP5350733B2 (ja) * 2008-09-30 2013-11-27 株式会社クレハ ホスホン酸、ホスホン酸銅化合物、樹脂組成物及び積層体
US8846978B2 (en) 2009-04-06 2014-09-30 Imperial Innovations Ltd. Electronic devices comprising novel phosphonic acid surface modifiers
US7960456B2 (en) * 2009-05-27 2011-06-14 Bromine Compounds Ltd. Halogenated phosphonates, processes for their preparation and their use as flame retardants
US8614200B2 (en) 2009-07-21 2013-12-24 Chimerix, Inc. Compounds, compositions and methods for treating ocular conditions
WO2011017253A1 (en) 2009-08-03 2011-02-10 Chimerix, Inc. Composition and methods of treating viral infections and viral induced tumors
EP3216789A1 (en) 2010-02-12 2017-09-13 Chimerix, Inc. Methods of treating viral infection
CA2797601A1 (en) 2010-04-26 2011-11-10 Chimerix, Inc. Methods of treating retroviral infections and related dosage regimes
EP4174077A1 (en) * 2021-10-27 2023-05-03 Merck Patent GmbH Electronic switching device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2917533A (en) * 1954-05-12 1959-12-15 Virginia Carolina Chem Corp Dialkylaminoalkyl esters of phosphonic acid and method of preparing same
US3363032A (en) * 1964-06-11 1968-01-09 Monsanto Co Long chain aliphatic benzylphosphonic acids, esters and salts
DE3339383A1 (de) * 1983-10-29 1985-05-09 Bayer Ag, 5090 Leverkusen Distyrylverbindungen
US4822780A (en) * 1987-07-08 1989-04-18 Otsuka Pharmaceutical Factory, Inc. Carboxamide compounds
DE4003054A1 (de) * 1990-02-02 1991-08-08 Hoechst Ag Verwendung von benzylphosphonsaeurederivaten zur behandlung von durch viren verursachte krankheiten
US5300687A (en) * 1991-07-18 1994-04-05 Ortho Pharmaceutical Corporation Trifluoromethylbenzylphosphonates useful in treating osteoporosis

Also Published As

Publication number Publication date
KR930002364A (ko) 1993-02-23
FI923289A0 (fi) 1992-07-17
ZA925391B (en) 1994-01-17
CA2074020A1 (en) 1993-01-19
JPH05213977A (ja) 1993-08-24
US5532226A (en) 1996-07-02
AU1965692A (en) 1993-01-21
NO922851L (no) 1993-01-19
US5300687A (en) 1994-04-05
HU9202353D0 (en) 1992-10-28
AU657146B2 (en) 1995-03-02
TW216796B (enExample) 1993-12-01
MX9204229A (es) 1993-04-01
CN1070408A (zh) 1993-03-31
NO922851D0 (no) 1992-07-17
FI923289L (fi) 1993-01-19
IE922341A1 (en) 1993-01-27
EP0524023A1 (en) 1993-01-20
HUT62907A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
FI923289A7 (fi) Osteoporoosin käsittelyyn käytettävät trifluorimetyylibentsyylifosfonaatit
FI935394L (fi) Foerbaettringar i betraeffande kontrastmedel
FI925387A0 (fi) Soekarrangemang i centralsystem foer cellulaer mobiltelefoni
FI930855A7 (fi) Tillaempningarnas modularitet i datakommunikationscentraler
FI932742L (fi) Riktningsseparator/kopplingskrets foer medelfrekvensbaerstroemmar i svagstroemsellinje
FI931260L (fi) I tjocktarmen koloniserande lactobacillus-stammar
FI933855A7 (fi) Kontinuerlig blandningsmaskin uppdelad i sektioner
FI935878L (fi) Porfycenfoereningar foer fotodynamisk terapi
FI932245L (fi) Faskombinationsfoerfarande och -anordning foer anvaendning i en flerantennmottagare
FI922166L (fi) Vattenhaltig kalciumcitratkomposition
FI921435L (fi) Skydd foer saenkpump i svaora foerhaollanden
FI88567B (fi) En generell synkronisk 2n+1 -divisor
FI922759L (fi) Loesningsmedelskompositioner foer anvaendning i tryckkaensligt kopieringspapper
FI923724A7 (fi) Monterings- och distansanordning foer braenslestavarna i en kokvattenreaktor
FI924744L (fi) Terapeutiska aemnen
DE69209162D1 (de) Recarbonisierung von Wasser
FI925206A0 (fi) Rengoerningsprodukt i vaetskeform
FI935507A7 (fi) Foerbaettring i en lyftbommekanism
FI921191L (fi) Tryckluftsfoersoerjningsanordning foer tryckluftsanlaeggningar i fordon
FI924750A0 (fi) Zirkoniumbaserad legering foer komponenter i kaernreaktorer
DE69125187D1 (de) Abfallbehandlung
FI922180L (fi) Tuggummi innehaollande tuggummibas i en valsningsblandning
DE69225104D1 (de) PCT-Zusammensetzung
FI915200L (fi) Foerfarande foer olineaer signalbehandling i en ekoslaeckare
FI922173L (fi) Externt justerbar styranordning foer stroemningsbegraensgning i tallriksventiler

Legal Events

Date Code Title Description
FD Application lapsed